Hengshuai Zhang
Chongqing, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome.
Journal: Biochemical pharmacology
Published: April 12, 2022
Decreased autophagic activity of detrusor cells is involved in the inflammatory response of interstitial cystitis/bladder pain syndrome.
Journal: International urogynecology journal
Published: January 06, 2022
Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization.
Journal: Drug design, development and therapy
Published: August 26, 2021
Estrogen inhibits bladder overactivity in rats with cyclophosphamide-induced cystitis via downregulating the expression of P2X3 receptors in bladder epithelium cells.
Journal: Neurourology and urodynamics
Published: August 17, 2021
Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-κB Pathways.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: August 05, 2021
Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.
Journal: Drug design, development and therapy
Published: July 16, 2021
Increased transient receptor potential canonical 3 activity is involved in the pathogenesis of detrusor overactivity by dynamic interaction with Na+/Ca2+ exchanger 1.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 07, 2021
Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1.
Journal: Biochemical pharmacology
Published: September 16, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026